$NEO
NEOGENOMICS INC

2015 Q2 Form 10-Q Financial Statement

#000119312515272903 Filed on July 31, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $24.37M $20.67M
YoY Change 17.9% 32.47%
Cost Of Revenue $13.56M $10.43M
YoY Change 29.97% 23.5%
Gross Profit $10.81M $10.24M
YoY Change 5.61% 43.06%
Gross Profit Margin 44.37% 49.54%
Selling, General & Admin $9.982M $9.028M
YoY Change 10.57% 49.57%
% of Gross Profit 92.31% 88.17%
Research & Development $803.0K $633.0K
YoY Change 26.86% 2.76%
% of Gross Profit 7.43% 6.18%
Depreciation & Amortization $1.760M $1.300M
YoY Change 35.38% 17.12%
% of Gross Profit 16.28% 12.7%
Operating Expenses $10.79M $9.661M
YoY Change 11.63% 45.23%
Operating Profit $28.00K $578.0K
YoY Change -95.16% 14.46%
Interest Expense -$200.0K -$300.0K
YoY Change -33.33% 50.0%
% of Operating Profit -714.29% -51.9%
Other Income/Expense, Net -$189.0K -$253.0K
YoY Change -25.3%
Pretax Income -$161.0K $325.0K
YoY Change -149.54% 19.05%
Income Tax $15.00K $51.00K
% Of Pretax Income 15.69%
Net Earnings -$176.0K $274.0K
YoY Change -164.23% 0.37%
Net Earnings / Revenue -0.72% 1.33%
Basic Earnings Per Share $0.00 $0.01
Diluted Earnings Per Share $0.00 $0.01
COMMON SHARES
Basic Shares Outstanding 60.43M 49.89M
Diluted Shares Outstanding 60.43M 53.73M

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.00M $5.000M
YoY Change 560.0% 8.7%
Cash & Equivalents $32.95M $5.023M
Short-Term Investments
Other Short-Term Assets $2.100M $1.600M
YoY Change 31.25% 100.0%
Inventory $3.416M $2.616M
Prepaid Expenses
Receivables $21.13M $18.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $59.60M $28.08M
YoY Change 112.24% 21.04%
LONG-TERM ASSETS
Property, Plant & Equipment $16.29M $12.97M
YoY Change 25.53% 54.45%
Goodwill $2.929M
YoY Change
Intangibles $2.466M
YoY Change
Long-Term Investments
YoY Change
Other Assets $128.0K $116.0K
YoY Change 10.34% -42.0%
Total Long-Term Assets $23.37M $15.56M
YoY Change 50.2% 37.66%
TOTAL ASSETS
Total Short-Term Assets $59.60M $28.08M
Total Long-Term Assets $23.37M $15.56M
Total Assets $82.97M $43.64M
YoY Change 90.12% 26.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.059M $6.081M
YoY Change -0.36% 78.85%
Accrued Expenses $5.200M $651.0K
YoY Change 698.77% -77.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.000M
YoY Change -100.0% -37.5%
Long-Term Debt Due $3.900M $3.100M
YoY Change 25.81% 19.23%
Total Short-Term Liabilities $15.13M $15.23M
YoY Change -0.66% 25.83%
LONG-TERM LIABILITIES
Long-Term Debt $6.200M $4.700M
YoY Change 31.91% 56.67%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $6.974M $5.279M
YoY Change 32.11% 75.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.13M $15.23M
Total Long-Term Liabilities $6.974M $5.279M
Total Liabilities $22.10M $20.51M
YoY Change 7.77% 36.7%
SHAREHOLDERS EQUITY
Retained Earnings -$20.34M -$20.16M
YoY Change 0.9%
Common Stock $81.21M $43.29M
YoY Change 87.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $60.87M $23.13M
YoY Change
Total Liabilities & Shareholders Equity $82.97M $43.64M
YoY Change 90.12% 26.49%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$176.0K $274.0K
YoY Change -164.23% 0.37%
Depreciation, Depletion And Amortization $1.760M $1.300M
YoY Change 35.38% 17.12%
Cash From Operating Activities $2.690M $4.270M
YoY Change -37.0% 129.57%
INVESTING ACTIVITIES
Capital Expenditures -$340.0K -$1.090M
YoY Change -68.81% 194.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$340.0K -$1.090M
YoY Change -68.81% 194.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -640.0K -3.550M
YoY Change -81.97% 138.26%
NET CHANGE
Cash From Operating Activities 2.690M 4.270M
Cash From Investing Activities -340.0K -1.090M
Cash From Financing Activities -640.0K -3.550M
Net Change In Cash 1.710M -370.0K
YoY Change -562.16%
FREE CASH FLOW
Cash From Operating Activities $2.690M $4.270M
Capital Expenditures -$340.0K -$1.090M
Free Cash Flow $3.030M $5.360M
YoY Change -43.47% 140.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60510045 shares
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5023000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5522971 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.91
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60503996 shares
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2739622 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60503996 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.51
CY2015Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6974000
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
81148000
CY2015Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1231000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3940000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
60867000
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
890000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6059000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4194000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20342000
CY2015Q2 us-gaap Liabilities
Liabilities
22099000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82966000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
61000
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23069000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
15125000
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
821000
CY2015Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3895000
CY2015Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
6153000
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3700000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
128000
CY2015Q2 us-gaap Assets
Assets
82966000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
372000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
372000
CY2015Q2 us-gaap Inventory Net
InventoryNet
3416000
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21130000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
186000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16286000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
372000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1976000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
372000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
59601000
CY2015Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4912000
CY2015Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
821000
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4022000
CY2015Q2 us-gaap Goodwill
Goodwill
2929000
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1282000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32952000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
372000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4834000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4012096 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.04
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60242818 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60242818 shares
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
6078000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79751000
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1208000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3897000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
60405000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
700000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6294000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4180000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19406000
CY2014Q4 us-gaap Liabilities
Liabilities
20701000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81106000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
60000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19822000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14623000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
821000
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3224000
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5257000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
141000
CY2014Q4 us-gaap Assets
Assets
81106000
CY2014Q4 us-gaap Inventory Net
InventoryNet
2616000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20475000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15082000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
58742000
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4912000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
821000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4212000
CY2014Q4 us-gaap Goodwill
Goodwill
2929000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1141000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33689000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
5298000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53551000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49590000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1966000
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
1615000
us-gaap Net Income Loss
NetIncomeLoss
376000
us-gaap Interest Paid
InterestPaid
498000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
38852000
us-gaap Operating Income Loss
OperatingIncomeLoss
972000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
315000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1960000
us-gaap Income Taxes Paid
IncomeTaxesPaid
170000
us-gaap Gross Profit
GrossProfit
18948000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-518000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-34000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-38000
us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
99004000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
3321000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
454000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78000
us-gaap Share Based Compensation
ShareBasedCompensation
246000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5791000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-2292000
us-gaap Operating Expenses
OperatingExpenses
17976000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1966000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3143000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1261000
us-gaap Cost Of Services
CostOfServices
19904000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
189000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
246000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
764000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10924000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
25000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
111000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2400000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
2494000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1814000
neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
60152000
neo Share Based Compensation On Warrant
ShareBasedCompensationOnWarrant
35000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1897000
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001077183
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.48
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.77
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
NEOGENOMICS INC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60352000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1723500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.54
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-13000
us-gaap Income Taxes Paid
IncomeTaxesPaid
20000
us-gaap Gross Profit
GrossProfit
20356000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-384000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1958000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
141000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60352000 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
207625 shares
dei Trading Symbol
TradingSymbol
NEO
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1180000
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
1833000
us-gaap Net Income Loss
NetIncomeLoss
-937000
us-gaap Interest Paid
InterestPaid
417000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
47396000
us-gaap Operating Income Loss
OperatingIncomeLoss
-534000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
800000
us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
110333000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
3400000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-918000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000
us-gaap Share Based Compensation
ShareBasedCompensation
813000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5821000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3249000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
813000
us-gaap Operating Expenses
OperatingExpenses
20890000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1180000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1454000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1471000
us-gaap Cost Of Services
CostOfServices
27040000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-737000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
379000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-41000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1303000
neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
62937000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13598000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
190000
neo Share Based Compensation On Warrant
ShareBasedCompensationOnWarrant
207000
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53733000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49890000 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
274000
CY2014Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
20670000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
578000
CY2014Q2 us-gaap Gross Profit
GrossProfit
10239000
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-253000
CY2014Q2 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
57805000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
325000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51000
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3158000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
9661000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
633000
CY2014Q2 us-gaap Cost Of Services
CostOfServices
10431000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
157000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5870000
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
55000
CY2014Q2 neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
37135000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60425000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60425000 shares
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-176000
CY2015Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
24370000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
28000
CY2015Q2 us-gaap Gross Profit
GrossProfit
10813000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-189000
CY2015Q2 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
56702000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-161000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2907000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
10785000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
803000
CY2015Q2 us-gaap Cost Of Services
CostOfServices
13557000
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
508000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7075000
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
97000
CY2015Q2 neo Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
32332000

Files In Submission

Name View Source Status
0001193125-15-272903-index-headers.html Edgar Link pending
0001193125-15-272903-index.html Edgar Link pending
0001193125-15-272903.txt Edgar Link pending
0001193125-15-272903-xbrl.zip Edgar Link pending
d935395d10q.htm Edgar Link pending
d935395dex311.htm Edgar Link pending
d935395dex312.htm Edgar Link pending
d935395dex313.htm Edgar Link pending
d935395dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
neo-20150630.xml Edgar Link completed
neo-20150630.xsd Edgar Link pending
neo-20150630_cal.xml Edgar Link unprocessable
neo-20150630_def.xml Edgar Link unprocessable
neo-20150630_lab.xml Edgar Link unprocessable
neo-20150630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending